| Authors: |
Muik A; BioNTech, Mainz, Germany., Garralda E; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Altintas I; Genmab B.V., Utrecht, the Netherlands., Gieseke F; BioNTech, Mainz, Germany., Geva R; Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Ben-Ami E; Department of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel., Maurice-Dror C; Institute of Oncology, Rambam Health Care Campus, Haifa, Israel., Calvo E; START Madrid-CIOCC, Clara Campal Comprehensive Cancer Center, Madrid, Spain., LoRusso PM; Yale Cancer Center, Yale University, New Haven, Connecticut., Alonso G; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Rodriguez-Ruiz ME; Radiation Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain., Schoedel KB; BioNTech, Mainz, Germany., Blum JM; Genmab U.S. Inc., Princeton, New Jersey., Sänger B; BioNTech, Mainz, Germany., Salcedo TW; Genmab U.S. Inc., Princeton, New Jersey., Burm SM; Genmab B.V., Utrecht, the Netherlands., Stanganello E; TRON gGmbH, Translational Oncology at the University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Verzijl D; Genmab B.V., Utrecht, the Netherlands., Vascotto F; TRON gGmbH, Translational Oncology at the University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Sette A; Genmab B.V., Utrecht, the Netherlands., Quinkhardt J; BioNTech, Mainz, Germany., Plantinga TS; Genmab B.V., Utrecht, the Netherlands., Toker A; BioNTech, Mainz, Germany., van den Brink EN; Genmab B.V., Utrecht, the Netherlands., Fereshteh M; TRON gGmbH, Translational Oncology at the University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Diken M; BioNTech, Mainz, Germany., Satijn D; Genmab B.V., Utrecht, the Netherlands., Kreiter S; BioNTech, Mainz, Germany., Breij ECW; Genmab B.V., Utrecht, the Netherlands., Bajaj G; Genmab U.S. Inc., Princeton, New Jersey., Lagkadinou E; BioNTech, Mainz, Germany., Sasser K; Genmab U.S. Inc., Princeton, New Jersey., Türeci Ö; BioNTech, Mainz, Germany., Forssmann U; Genmab A/S, Copenhagen, Denmark., Ahmadi T; Genmab U.S. Inc., Princeton, New Jersey., Şahin U; BioNTech, Mainz, Germany., Jure-Kunkel M; Genmab U.S. Inc., Princeton, New Jersey., Melero I; Department of Immunology, Clínica Universidad de Navarra and CIBERONC, Pamplona, Spain. |
